Patents by Inventor Wenxiao GONG

Wenxiao GONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240143105
    Abstract: A touch sensor and a display apparatus are disclosed. The touch sensor includes a first opening region, first touch electrodes and second touch electrodes. The first touch electrodes respectively extend along a first direction, and at least one of the first touch electrodes includes first touch sub-electrodes arranged side by side in the first direction and electrically connected with each other; the second touch electrodes respectively extend along a second direction, and at least one of the second touch electrodes includes second touch sub-electrodes arranged side by side in the second direction and electrically connected with each other; an area of a first touch sub-electrode in the first region is less than that of a first touch sub-electrode in the third region, or an area of a second touch sub-electrode in the first region is less than that of a second touch sub-electrode in the third region.
    Type: Application
    Filed: January 8, 2024
    Publication date: May 2, 2024
    Applicants: Chengdu BOE Optoelectronics Technology Co., Ltd., BOE TECHNOLOGY GROUP CO., LTD.
    Inventors: Wenxiao NIU, Hengzhen LIANG, Qing GONG, Shiheng MU
  • Patent number: 11786566
    Abstract: Bifidobacterium animalis and application of a compound bacterium preparation prepared from the Bifidobacterium animalis in the preparation of a medicine for treating or preventing avian influenza virus infection. The invention discovers that Bifidobacterium animalis ATCC Accession No. 25527 can be used for treating animals infected by H7N9, and after the Bifidobacterium animalis ATCC Accession No. 25527 is compounded with Bifidobacterium pseudolongum ATCC Accession No. 25526, the effect is better. The compound preparation can regulate the body immune response, remarkably improve the weight loss and lung tissue injury caused by H7N9 influenza virus infection, and obviously improve the survival rate of mice infected by H7N9 influenza virus. The compound probiotic preparation provided by the invention has a remarkable effect of resisting H7N9 influenza virus infection, and can be effectively used for preventing and treating avian influenza virus infection.
    Type: Grant
    Filed: January 4, 2021
    Date of Patent: October 17, 2023
    Assignee: Huazhong Agricultural University
    Inventors: Meilin Jin, Qiang Zhang, Xiaotong Hu, Li Yang, Jin Hu, Ting Wang, Xiaomei Sun, Zhong Zou, Wenxiao Gong, Xian Lin
  • Publication number: 20210213075
    Abstract: Bifidobacterium animalis and application of a compound bacterium preparation prepared from the Bifidobacterium animalis in the preparation of a medicine for treating or preventing avian influenza virus infection. The invention discovers that Bifidobacterium animalis ATCC Accession No. 25527 can be used for treating animals infected by H7N9, and after the Bifidobacterium animalis ATCC Accession No. 25527 is compounded with Bifidobacterium pseudolongum ATCC Accession No. 25526, the effect is better. The compound preparation can regulate the body immune response, remarkably improve the weight loss and lung tissue injury caused by H7N9 influenza virus infection, and obviously improve the survival rate of mice infected by H7N9 influenza virus. The compound probiotic preparation provided by the invention has a remarkable effect of resisting H7N9 influenza virus infection, and can be effectively used for preventing and treating avian influenza virus infection.
    Type: Application
    Filed: January 4, 2021
    Publication date: July 15, 2021
    Inventors: Meilin JIN, Qiang ZHANG, Xiaotong HU, Li YANG, Jin HU, Ting WANG, Xiaomei SUN, Zhong ZOU, Wenxiao GONG, Xian LIN